John D. Ulm

Array ( [id] => 4069964 [patent_doc_number] => 06068994 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-30 [patent_title] => 'Ubiquitin expression system' [patent_app_type] => 1 [patent_app_number] => 8/428278 [patent_app_country] => US [patent_app_date] => 1995-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8753 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/068/06068994.pdf [firstpage_image] =>[orig_patent_app_number] => 428278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3743977 [patent_doc_number] => 05716804 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => 'Mammalian interleukin-10 (IL-10) super-activating receptors; and variants' [patent_app_type] => 1 [patent_app_number] => 8/424788 [patent_app_country] => US [patent_app_date] => 1995-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 8177 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/716/05716804.pdf [firstpage_image] =>[orig_patent_app_number] => 424788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3807816 [patent_doc_number] => 05831007 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Human receptor for interleukin-12' [patent_app_type] => 1 [patent_app_number] => 8/419652 [patent_app_country] => US [patent_app_date] => 1995-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 35 [patent_no_of_words] => 17134 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/831/05831007.pdf [firstpage_image] =>[orig_patent_app_number] => 419652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3884251 [patent_doc_number] => 05723299 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'Somatostatin receptors' [patent_app_type] => 1 [patent_app_number] => 8/417103 [patent_app_country] => US [patent_app_date] => 1995-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 16922 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723299.pdf [firstpage_image] =>[orig_patent_app_number] => 417103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3847280 [patent_doc_number] => 05719057 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-17 [patent_title] => 'Stably human transfected rodent fibroblast cell line expressing human GABA-A recepotors, and cloned human GABA-A receptor subunit CDNA sequences' [patent_app_type] => 1 [patent_app_number] => 8/417330 [patent_app_country] => US [patent_app_date] => 1995-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 8162 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/719/05719057.pdf [firstpage_image] =>[orig_patent_app_number] => 417330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3866186 [patent_doc_number] => 05837500 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Directed evolution of novel binding proteins' [patent_app_type] => 1 [patent_app_number] => 8/415922 [patent_app_country] => US [patent_app_date] => 1995-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 137808 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837500.pdf [firstpage_image] =>[orig_patent_app_number] => 415922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3508871 [patent_doc_number] => 05563039 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-08 [patent_title] => 'TNF receptor-associated intracellular signaling proteins and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/414625 [patent_app_country] => US [patent_app_date] => 1995-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11156 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/563/05563039.pdf [firstpage_image] =>[orig_patent_app_number] => 414625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686620 [patent_doc_number] => 05691170 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-25 [patent_title] => 'Generation of hybrid genes and proteins by virus-mediated recombination' [patent_app_type] => 1 [patent_app_number] => 8/412609 [patent_app_country] => US [patent_app_date] => 1995-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 21 [patent_no_of_words] => 8665 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/691/05691170.pdf [firstpage_image] =>[orig_patent_app_number] => 412609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3509154 [patent_doc_number] => 05587301 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-24 [patent_title] => 'DNA encoding a hyaluronan receptor expressed in human umbilical vein endothelial cells' [patent_app_type] => 1 [patent_app_number] => 8/402217 [patent_app_country] => US [patent_app_date] => 1995-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9643 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/587/05587301.pdf [firstpage_image] =>[orig_patent_app_number] => 402217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3535166 [patent_doc_number] => 05556946 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-17 [patent_title] => 'Interleukin-2/viral antigen protein chimers' [patent_app_type] => 1 [patent_app_number] => 8/386354 [patent_app_country] => US [patent_app_date] => 1995-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 39 [patent_no_of_words] => 13119 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/556/05556946.pdf [firstpage_image] =>[orig_patent_app_number] => 386354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3790930 [patent_doc_number] => 05726036 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof' [patent_app_type] => 1 [patent_app_number] => 8/384828 [patent_app_country] => US [patent_app_date] => 1995-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 35 [patent_no_of_words] => 16208 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/726/05726036.pdf [firstpage_image] =>[orig_patent_app_number] => 384828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3630677 [patent_doc_number] => 05686573 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Human D5 dopamine receptor protein' [patent_app_type] => 1 [patent_app_number] => 8/383781 [patent_app_country] => US [patent_app_date] => 1995-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9034 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686573.pdf [firstpage_image] =>[orig_patent_app_number] => 383781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3831442 [patent_doc_number] => 05712149 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-27 [patent_title] => 'Chimeric receptor molecules for delivery of co-stimulatory signals' [patent_app_type] => 1 [patent_app_number] => 8/383749 [patent_app_country] => US [patent_app_date] => 1995-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 15090 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/712/05712149.pdf [firstpage_image] =>[orig_patent_app_number] => 383749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3739838 [patent_doc_number] => 05786203 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-28 [patent_title] => 'Isolated nucleic acid encoding corticotropin-releasing factor.sub.2 receptors' [patent_app_type] => 1 [patent_app_number] => 8/381433 [patent_app_country] => US [patent_app_date] => 1995-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18302 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/786/05786203.pdf [firstpage_image] =>[orig_patent_app_number] => 381433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3659784 [patent_doc_number] => 05648259 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Polypeptides having NMDA receptor activity, nucleic acids encoding those polypeptides and applications' [patent_app_type] => 1 [patent_app_number] => 8/356397 [patent_app_country] => US [patent_app_date] => 1995-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 5808 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648259.pdf [firstpage_image] =>[orig_patent_app_number] => 356397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3823965 [patent_doc_number] => 05731195 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-24 [patent_title] => 'Isolated nucleic acid molecule which codes for a 32 kDa protein having 11-cis retinol dehydrogenase activity, and which associates with p63, a portion of a retinol binding protein receptor' [patent_app_type] => 1 [patent_app_number] => 8/375962 [patent_app_country] => US [patent_app_date] => 1995-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 8164 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/731/05731195.pdf [firstpage_image] =>[orig_patent_app_number] => 375962 [rel_patent_id] =>[rel_patent_doc_number] =>)